Bronchi-Shield, Lyophilisate and Solvent for Suspension for Nasal Drops for Dogs
Bronchi-Shield, Lyophilisate and Solvent for Suspension for Nasal Drops for Dogs
Authorised
- Water for injection
- Bordetella bronchiseptica, strain 92 B, Live
Product identification
Medicine name:
BRONCHI-SHIELD
Bronchi-Shield, Lyophilisate and Solvent for Suspension for Nasal Drops for Dogs
Active substance:
- Water for injection
- Bordetella bronchiseptica, strain 92 B, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Water for injection1.00/millilitre(s)1.00Dose
-
Bordetella bronchiseptica, strain 92 B, Live2100000.00/Colony forming unit1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for nasal administration
Withdrawal period by route of administration:
-
Nasal use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Package description:
- Box containing 10 vials of 1 dose of lyophilisate and 10 vials of 1 dose of solvent and 10 cannulae for application
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis UK Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- VMD
Authorisation number:
- Vm 42058/4011
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0153/001
Concerned member states:
-
Belgium
-
Germany
-
Hungary
-
Ireland
-
Luxembourg
-
Netherlands
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
